SANUWAVE director granted 5,524 stock options

SANUWAVE Health director Tyler James received a new stock option grant.

Accepted by SEC EDGAR 07/02/2026 - 04:12 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SANUWAVE Health director Tyler James received a new stock option grant. He was awarded options covering 5,524 shares of Common Stock at an exercise price of $10.0000 per share. The options were fully vested on the grant date and expire on June 30, 2031. Following this grant, he holds 5,524 derivative securities directly.

Insider Trade Summary

Grant/Award: 5,524 shares

Grant/Award 1 txn

Insider Tyler James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	5,524	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 5,524 contracts (Direct)

Holdings Before and After: Stock Option (right to buy), 0 to 5,524 contracts (Direct)

Footnotes (1)

F1. Options were fully vested at the grant date.

Key Figures

Option grant size: 5,524 options Exercise price: $10.0000 per share Underlying shares: 5,524 shares +3 more

6 metrics

Option grant size 5,524 options Stock Option (right to buy) granted on June 30, 2026

Exercise price $10.0000 per share Conversion or exercise price for granted options

Underlying shares 5,524 shares Underlying Common Stock for the option grant

Total derivatives after grant 5,524 options Total derivative securities held following the transaction

Option expiration June 30, 2031 Expiration date of the granted stock options

Grant vesting Fully vested at grant Footnote states options were fully vested at grant date

Key Terms

Stock Option (right to buy), Common Stock, Grant, award, or other acquisition, fully vested

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

fully vested financial

"Options were fully vested at the grant date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tyler James report in his latest Form 4 for SANUWAVE Health (SNVW)?

Tyler James reported receiving a grant of stock options for 5,524 shares of SANUWAVE Health Common Stock. The options carry a $10.0000 exercise price, were fully vested at grant, and expire on June 30, 2031, reflecting a compensation-related award.

How many SANUWAVE Health (SNVW) shares are covered by Tyler James’s new options?

The new option grant covers 5,524 shares of SANUWAVE Health Common Stock. These options give him the right to buy that number of shares at a fixed $10.0000 per-share exercise price through their stated expiration date in 2031.

What is the exercise price of Tyler James’s SANUWAVE Health (SNVW) stock options?

The stock options granted to Tyler James have an exercise price of $10.0000 per share. This means he can purchase up to 5,524 SANUWAVE Health Common Stock shares at that price any time before the options expire in June 2031.

When do Tyler James’s SANUWAVE Health (SNVW) stock options expire?

Tyler James’s stock options expire on June 30, 2031. Until that expiration date, he may choose to exercise the options to buy up to 5,524 shares of SANUWAVE Health Common Stock at the fixed $10.0000 exercise price.

Were Tyler James’s SANUWAVE Health (SNVW) options subject to vesting?

The filing states that Tyler James’s options were fully vested at the grant date. This means all 5,524 option shares became exercisable immediately, with no additional service or performance conditions required before he can exercise them.

Does Tyler James’s Form 4 for SANUWAVE Health (SNVW) show any stock sales or purchases?

The Form 4 only reports a grant of stock options classified as a grant, award, or other acquisition. It does not show any open-market purchases or sales of SANUWAVE Health Common Stock by Tyler James in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tyler James

(Last)

(First)

(Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$10	06/30/2026		A		5,524		⁽¹⁾	06/30/2031	Common Stock	5,524	$0	5,524	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for James Tyler	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR